We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current XLO market cap is 49.23M. The company's latest EPS is USD -1.7381 and P/E is -0.54.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 2.36M | 2.26M |
| Operating Income | -17.36M | -18.13M | -17.49M | -14.7M | -14.76M |
| Net Income | -16.75M | -17.66M | -17.2M | -13.93M | -14.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.03M | -54.56M | -75.04M | -89.15M | -79.13M |
| Net Income | -17.31M | -55.22M | -75.8M | -88.22M | -76.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 77.84M | 60.93M | 82.61M | 89.87M | 74.66M |
| Total Liabilities | 25.34M | 24.1M | 56.84M | 56.46M | 53.68M |
| Total Equity | 52.5M | 36.83M | 25.77M | 33.42M | 20.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.72M | 36.32M | 218.06M | 139.17M | 60.93M |
| Total Liabilities | 24.21M | 41.6M | 32.63M | 33.52M | 24.1M |
| Total Equity | -29.52M | -83.29M | 185.43M | 105.65M | 36.83M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -55.19M | -68.62M | -10.5M | 9.45M | -4.22M |
| Investing | -486k | -486k | N/A | -21k | -30k |
| Financing | -4.92M | -6.55M | 954k | 21M | 20.99M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.84M | -36.09M | -80.75M | -75.72M | -68.62M |
| Investing | -715k | -2.19M | -1.1M | -1.87M | -486k |
| Financing | 60.02M | 10.03M | 260.67M | -69k | -6.55M |
| Market Cap | 49.23M |
| Price to Earnings Ratio | -0.54 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.92 |
| Price to Book Ratio | 1.12 |
| Dividend Yield | - |
| Shares Outstanding | 43.96M |
| Average Volume (1 week) | 1.05M |
| Average Volume (1 Month) | 343.24k |
| 52 Week Change | 85.43% |
| 52 Week High | 1.93 |
| 52 Week Low | 0.49 |
| Spread (Intraday) | 0.02 (1.77%) |
| Company Name | Xilio Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://xiliotx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
